July 2022: China Registry Update

Suspension of Supplementary Registration

From July 05, 2022, the Chinese Clinical Trial Registry (ChiCTR) has suspended supplementary registration of Clinical Trials.

Supplementary registration is defined as the registration done after the first case of candidate is recruited.

There have been no other changes made to the information available for supplementary registrations on the ChiCTR website.